Na Kong
Papers
1
Total Citations
2
H-Index
1
About
Dr. Na Kong is a leading researcher at the intersection of nanomedicine and drug delivery, with a primary focus on overcoming biological barriers for oral peptide and protein therapeutics. Her most impactful work centers on the development of innovative oral insulin delivery platforms, a critical challenge in diabetes management. Dr. Kong’s research systematically addresses the formidable biological obstacles—from the harsh gastrointestinal environment to the intestinal epithelial barrier—that have historically limited the clinical translation of oral biologics. Her contributions, often in collaboration with pioneers O. C. Farokhzad and W. Tao, have been highlighted in high-impact venues, including a notable Minireview in *Angewandte Chemie International Edition* (2020). This work, which has garnered early citations, systematically categorizes and evaluates strategies such as moiety-mediated transport and nanoparticle-based encapsulation, providing a foundational roadmap for the field. By elucidating these design principles, Dr. Kong is helping to pave the way for non-invasive, patient-friendly alternatives to injectable insulin, positioning her as an emerging authority in advanced drug delivery systems.
Research Focus
Key Achievements
Top Papers
- 1